Portfolio company
Micromet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops antibody therapies for cancer and autoimmune disease treatment for patients and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Reverb Therapeutics
This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.
Zymeworks
The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Innate Pharma
This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.
Solu Therapeutics
This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Biogen Idec
This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.
